<template>
	<div class="pt-20">
		<h1 class="text-[32px] text-electric-blue font-effra font-medium leading-normal max-w-[920px]">
			EXBLIFEP® achieved superiority in overall treatment success* in patients with cUTIs vs piperacillin/tazobactam<sup>1</sup>
		</h1>
		<img
			src="../assets/images/lime-green-border.png"
			alt="Lime Green Border"
			class="h-1.5 w-auto my-5"
		/>
		<p class="max-w-[1300px] text-xl font-effra leading-normal">
			In ALLIUM, EXBLIFEP® demonstrated both non-inferiority and statistical superiority in overall treatment success (a composite endpoint of clinical
			cure and microbiological eradication) at Day 14 vs piperacillin/tazobactam in patients in the PAS with cUTIs caused by gram-negative pathogens1
		</p>
	</div>
</template>
